1. 1017. Residual Infusion Performance Evaluation (RIPE): A Single-Center Evaluation of Residual Volume Post-Intravenous Eravacycline Infusion. (15th December 2022) Authors: Baumann, Alysa J; Cleveland, Kerry O; Gelfand, Michael S; Perkins, Nicholson B; Covington, Angela D; Hobbs, Athena L V Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1577. Real-World, Multicenter Experience with Eravacycline for Various Infections. (31st December 2020) Authors: Alosaimy, Sara; Lagnf, Abdalhamid M; Molina, Kyle; King, Madeline; Pullinger, Benjamin; Tart, Serina; Jones, Bruce M; Claeys, Kimberly C; Truong, James; Andrade, Justin A; Biagi, Mark; Pierce, Michael; Cosimi, Reese; Hobbs, Athena L V; Perkins, Nicholson; Huang, Glen; Veve, Michael; Morrisette, T... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1791. The Impact of a β-lactam Allergy Assessment on Aztreonam Utilization Within a Healthcare System. (26th November 2018) Authors: Shea, Katherine; Knight, Tamara; Jaso, Theresa; Bissett, Jack; Moser, M Tanner; Hobbs, Athena L V Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2231. Assessing Clinical Cure of Empiric Piperacillin-Tazobactam for ESBL Urinary Tract Infections (ACCEPT-UTI). (15th December 2022) Authors: Stefanos, Sylvia; Gant, Jessie; Kermeen, Sydney; Sakaan, Sami; Samarin, Michael; Gelfand, Michael S; Cleveland, Kerry O; Hobbs, Athena L V Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 633. Eravacycline Use in Immunocompromised Patients: Multicenter Evaluation of Clinical and Safety Endpoints. (15th December 2022) Authors: Kunz Coyne, Ashlan J; Allosaimy, Sara; Molina, Kyle C; Kang-Birken, Lena; Lagnf, Abdalhamid M; Claeys, Kimberly C; Veve, Michael; King, Madeline; Pullinger, Benjamin; Bouchard, Jeannette; Gore, Tristan; Rojas, Leonar; Tart, Serina; Hobbs, Athena L V; Perkins, Nicholas; Biagi, Mark; Pierce, Michae... Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 897. Criteria Restricting Inappropriate Meropenem Empiricism (CRIME): A Quasi-Experimental Carbapenem Restriction Pilot at a Large Academic Medical Center. (15th December 2022) Authors: Wells, Drew; Johnson, Asia; Lukas, Jack; Mason, Darius; Cleveland, Kerry O; Bissell, Aaron; Hobbs, Athena L V Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 920. Leveling Up: Evaluation of IV vs. PO Linezolid Utilization and Cost after an Antimicrobial Stewardship Program Revision of IV to PO Conversion Criteria within a Healthcare System. (15th December 2022) Authors: Jaggar, Jessica H; Cleveland, Kerry O; Twilla, Jennifer D; Patterson, Shanise; Hobbs, Athena L V Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Can't keep it SECRET: system evaluation of carbapenem restriction against empirical therapy. Issue 1 (2nd January 2023) Authors: Wells, Drew A; Johnson, Asia J; Lukas, Jack G; Hobbs, Diana A; Cleveland, Kerry O; Twilla, Jennifer D; Hobbs, Athena L V Journal: JAC-antimicrobial resistance Issue: Volume 5:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of the timing of MRSA PCR nasal screening: How long can a negative assay be used to rule out MRSA-positive respiratory cultures?. (31st March 2021) Authors: Turner, Stephen C; Seligson, Nathan D; Parag, Bhavyata; Shea, Katherine M; Hobbs, Athena L V Journal: American journal of health-system pharmacy Issue: Volume 78 (2021)Supplement 2 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam. (19th August 2022) Authors: Alosaimy, Sara; Lagnf, Abdalhamid M; Hobbs, Athena L V; Mubarez, Musa; Kufel, Wesley D; Morrisette, Taylor; Polisetty, Radhika S; Li, David; Veve, Michael P; Simon, Sam P; Truong, James; Finch, Natalie; Venugopalan, Veena; Rico, Matthew; Amaya, Lee; Yost, Christine; Cubillos, Ashley; Chandler, El... Journal: Clinical infectious diseases Issue: Volume 76:Number 3(2023) Page Start: e1444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗